Bölge seçiniz
Gönder

Haber akışımıza abone olun

Abone ol

Bir soru?

18.10.2024
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

“The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased by 3.5%, of which the organic increase was 0.2%, while the operating margin weakened compared with last year.

9.10.2024
FleetView by Getinge elevates service with connected devices

Building on over 15 years of experience in connected devices, Getinge now introduces FleetView. This web application represents the next step in data-driven device lifecyle management, offering healthcare providers and life science companies a tool to navigate large amounts of service data and statistical insights. Providing a vehicle to access the insights needed to optimize operational efficiency, FleetView is not only positioned to help customers reduce total cost of ownership but also helps enhance service reliability and uptime.  

4.10.2024
Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call

Getinge will issue its Q3 Report 2024 on October 18, 2024, at 08:00 a.m. CEST, followed by a conference call at 10.00-11.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

25.09.2024
Getinge’s CE certificate for ECLS consumables reinstated

The notified body, TÜV SÜD, reinstates Getinge’s CE certificate for HLS and PLS consumables, used for ECLS therapy, with certain conditions. Temporary challenges with a supplier and production changeover related to the new packaging solution have resulted in a lower volume of HLS and PLS sets available for shipment in Q3 2024, which is expected to be phased into Q4 2024.

11.09.2024
Getinge completes the acquisition of Paragonix Technologies

Getinge has today completed the previously announced acquisition of 100% of the shares of Paragonix Technologies, Inc.

1.09.2024
Getinge makes a provision of MBRL 240 related to Brazilian investigation

Getinge makes a provision of MBRL 240, corresponding to approximately MSEK 480, related to the previously announced negotiations with the Brazilian Comptroller General of the Union (CGU) involving violations of the Brazilian Clean Companies Act.

Basın iletişim

Lars Mattsson

Interim EVP Brand & Communication
Phone: +46 10 335 0043

Caroline Örmgård

Head of Public & Media Relations
Tel: +46 10 335 0041

Katarzyna Sypuła

Head of Marketing Communications CEE/MEA
Tel: +48 661 705 706

Newsroom2

Bizimle çevrimiçi iletişime geçmeyi mi tercih ediyorsunuz?

Uygun formu doldurmak için aşağıya tıklayın. Yakında sizinle iletişime geçeceğiz!

Mı arıyorsun

Getinge Hybrid OR

Resim Galerisi

Basın makalesi amacıyla kullanıma sunulan çeşitli resim formatı

Man and woman looking a something together

Hakkımızda

Bir bakışta Getinge hakkında bilmeniz gereken her şey

Cardiosave

Acil Tıbbi Cihaz Düzeltmesi

CARDIOSAVE intra-aortik balon pompası (IABP) için Gönüllü Acil Tıbbi Cihaz Saha Düzeltmesi

Newsroom

Hiçbir şeyi kaçırma

Simgelere tıklayın ve bizi takip edin!